Winship Physician Named Nation’s Leading Young Cancer Researcher

Dr. Fadlo Khuri, Winship Cancer Institute

Dr. Fadlo R. Khuri, surrounded by colleagues at Winship Cancer Institute, including institute executive director Dr. Walter J. Curran Jr., who stands to Khuri’s immediate right.

Winship Cancer Institute of Emory University deputy director, Fadlo R. Khuri, MD, one of the world’s leading experts in lung and other aerodigestive cancers, will be awarded the Richard and Hinda Rosenthal Memorial Award from the American Association for Cancer Research. The Rosenthal Award is given each year to an investigator under the age of 50 whose contributions to cancer research have led to new understandings of cancer and show promise for even greater advances in the future.

The award recognizes Dr. Khuri’s outstanding contributions and accomplishments as an investigator in lung and aerodigestive medical oncology, especially in the area of prevention and treatment of lung and head and neck cancers. He will receive the award April 10 at the AACR’s annual meeting in Washington, D.C.

Walter J. Curran, Jr., MD, executive director of Winship Cancer Institute, nominated Khuri for this award and said that the honor is not a surprise to those who know his work.

“Fadlo’s leadership in lung and head and neck cancer research is legendary, and he has helped advance our understanding of the nation’s number one cancer killer by introducing novel therapeutic agents that have changed how people live with this disease,” said Curran.

Khuri was instrumental in obtaining the National Cancer Institute (NCI) designation to Winship Cancer Institute in 2009. He holds the Roberto C. Goizueta Chair in translational research at Emory University School of Medicine and is also the Editor-in-chief of Cancer.

Dr. Khuri’s achievement illustrates one of many ways Winship Cancer Institute is helping patients win the fight against cancer. Congratulations, Dr. Khuri!

Related Resources:

Tags: , , , , , , , ,